Jennifer Pietenpol Archive — Page 2 of 6
-
October 6, 2021
Pierre Massion
-
September 30, 2021
We are making progress
-
September 30, 2021
A lasting gift
-
September 2, 2021
Discovery offers insight for development of cancer therapies targeting mutant p53
Vanderbilt researchers have discovered that aneuploidy (an abnormal number of chromosomes) drives malignant phenotypes in cells expressing mutant p53, a tumor suppressor protein that is mutated in more than half of all human cancers. -
August 19, 2021
Expression atlas for cell regulators
Vanderbilt researchers report a comprehensive tissue-specific atlas of protein and mRNA expression for p63 and p73, members of the p53 family signaling network that is the most frequent target of mutations in human cancers. -
March 1, 2021
Personalized Care
-
March 1, 2021
Expanded Footprint